Item
ASCORBIC ACID USP FN GR KOSHER TIANLI (3020672 215 09M)
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
Location name | Address |
---|---|
CSPC INNOVATION PHARMACEUTICAL - MITSUBISHI | NO. 36 FUQIANG WESTERN ROAD LUANCHENG COUNTY SHIJIAZHUANG CITY, HEBEI PROVINCE 0 CHN |
Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | South of Weigao Road, East of Xierhuan Road (Chenming Industrial Park) Shouguang, Weifang, SD 262700 CHN |
Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Chenming Industrial Park Shouguang, SD 1 CHN |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Phthalate Esters Letter | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | 0326.pdf | 8/9/2021 | 8/9/2022 |
CoA Sample | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | 3020672 ASCORBIC ACID USP FN GR KOSHER lot 012203053.pdf | 5/16/2024 | 5/16/2026 |
Allergens | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Allergens.pdf | 7/7/2020 | 7/7/2022 |
Allergens | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Allergens.pdf | 11/18/2022 | 11/17/2024 |
Animal Testing Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Animal Free Source Statement--VC.pdf | 7/30/2021 | 7/30/2023 |
No Animal Ingredient Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Animal testing Statement -- VC.pdf | 8/9/2021 | 8/9/2022 |
Animal Testing Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Animal testing Statement VC.pdf | 11/26/2023 | 11/25/2025 |
Heavy Metal | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | C--.PDF | 6/5/2020 | 6/5/2022 |
Residual Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | C--.pdf | 6/11/2021 | 6/11/2022 |
Pesticide | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | C--.pdf | 7/22/2020 | 7/22/2022 |
CoA Sample | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | COA-VC.pdf | 6/3/2020 | 6/3/2022 |
Ingredient Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | COMPOSITION DATASHEET Ascorbic ACid.pdf | 6/11/2021 | 6/11/2022 |
Ingredient Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | COMPOSITION DATASHEET Ascorbic Acid.pdf | 11/26/2023 | 11/25/2024 |
Country of Origin | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Country of Origin.pdf | 7/7/2020 | 7/7/2023 |
Country of Origin | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Country of Origin.pdf | 11/26/2023 | 11/25/2026 |
Dietary Supplement Questionnaire | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Dietary Supplement Questionnaire.pdf | 6/11/2021 | 6/11/2022 |
Dietary Supplement Questionnaire | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Dietary Supplement Questionnaire.pdf | 11/26/2023 | 11/25/2024 |
Environmental Policy | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | ENVIRONMENTAL MONITORING PROGRAM SUMMARY-VC.pdf | 11/29/2023 | 11/28/2024 |
EtO Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Ethylene Oxide (ETO)Irradiation (IRR)Ionization Statement VC.pdf | 11/26/2023 | 11/25/2025 |
HACCP Process Flow Diagram | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Flow Chart of Ascorbic Acid.pdf | 10/26/2020 | 10/26/2022 |
HARPC Food Safety Plan (Item) | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Food safety plan Statement.pdf | 6/5/2020 | 6/5/2023 |
HARPC Food Safety Plan (Item) | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Food safety plan Statement.pdf | 11/27/2023 | 11/26/2026 |
FSVP Assessment Form | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | FSVP Assessment Form.pdf | 6/11/2021 | 6/11/2022 |
FSVP Assessment Form | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | FSVP Assessment Form.pdf | 11/29/2023 | 11/28/2024 |
Gluten | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Gluten Statement.pdf | 6/11/2021 | 6/11/2022 |
Gluten | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Gluten Statement.pdf | 11/26/2023 | 11/25/2024 |
GRAS/NDI/ODI Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | GRAS Statement.pdf | 6/5/2020 | 6/5/2023 |
GRAS/NDI/ODI Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | GRAS Statement-VC.pdf | 11/26/2023 | 11/25/2026 |
Heavy Metal | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | heavy metal.pdf | 11/26/2023 | 11/25/2025 |
Halal | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | IFANCE HALAL-2024-VC.pdf | 4/6/2022 | 3/31/2024 |
Halal | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | IFANCE HALAL-2024-VC.pdf | 4/6/2022 | 3/31/2024 |
HACCP | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | ISO 22000.jpg | 6/5/2020 | 6/5/2023 |
Item Questionnaire | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Item Questionnaire.pdf | 7/13/2021 | 7/13/2022 |
Item Questionnaire | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Item Questionnaire.pdf | 11/26/2023 | 11/25/2026 |
Label Sample | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Label sample from Tianli.pdf | 4/26/2023 | 4/25/2024 |
Kosher | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | LM-QC-TLV-003-2022A-Kosher.pdf | 5/24/2022 | 5/31/2023 |
GMO | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | LM-QC-TLV-006-2022A-IP(Tianli).pdf | 9/15/2021 | 9/15/2023 |
HACCP Process Flow Diagram | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QD-01-001-20223A-MFC-VC.pdf | 1/31/2023 | 1/30/2025 |
Product Specification Sheet | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QD-01-001-2023A-SPEC VC.pdf | 1/9/2023 | 1/8/2026 |
HACCP | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | LM-QS-01-001-2023A-HACCP.pdf | 11/26/2023 | 11/25/2026 |
Lot Code | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | lot code explanation- VC-01.pdf | 11/26/2023 | 11/25/2026 |
Lot Code | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Lot Code.pdf | 6/5/2020 | 6/5/2023 |
Melamine | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Melamine Free Statement VC.pdf | 7/22/2020 | 7/22/2021 |
Melamine | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Melamine Free Statement-VC.pdf | 7/28/2021 | 7/28/2022 |
National Bioengineered Food Disclosure Standard (Simplified) | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | National Bioengineered Food Disclosure Standard (Simplified).pdf | 6/5/2020 | 6/5/2023 |
National Bioengineered Food Disclosure Standard (Simplified) | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | National Bioengineered Food Disclosure Standard (Simplified).pdf | 11/26/2023 | 11/25/2026 |
No Animal Ingredient Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | No Animal ingredients Statement VC.pdf | 11/29/2023 | 11/28/2024 |
EtO Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Non ETO Statement.pdf | 6/3/2020 | 6/3/2022 |
GMO | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | non-GMO Statement VC.pdf | 11/26/2023 | 11/25/2025 |
Irradiation Status Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | non-irradiation statement-ascorbic acid.pdf | 11/26/2023 | 11/25/2025 |
Irradiation Status Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | non-irradiation.pdf | 6/5/2020 | 6/5/2022 |
Natural | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Non-natural Statement-VC.pdf | 11/29/2023 | 11/28/2024 |
Nutrition | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Nutrition.pdf | 7/7/2020 | 7/7/2023 |
Nutrition | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Nutrition.pdf | 11/26/2023 | 11/25/2026 |
Organic | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Organic Compliance.pdf | 6/1/2021 | 6/30/2023 |
Organic | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Organic-VC.pdf | 11/26/2023 | 11/26/2026 |
Kosher | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | OUV2-2DEB1DC.pdf | 11/21/2023 | 5/31/2024 |
Food Contact Packaging Certificate of Compliance | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Packaging Statement.pdf | 11/26/2023 | 11/25/2025 |
Label Guidance | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | packing specification.pdf | 6/5/2020 | 6/5/2022 |
Label Claims | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | packing specification.pdf | 6/5/2020 | 6/5/2022 |
Label Sample | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | packing specification.pdf | 6/11/2021 | 6/11/2022 |
Label Guidance | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | packing specification.pdf | 6/5/2020 | 6/5/2022 |
Label Claims | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | packing specification.pdf | 6/5/2020 | 6/5/2022 |
Food Contact Packaging Certificate of Compliance | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | PE bags test report.pdf | 6/5/2020 | 6/5/2022 |
Pesticide | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Pesticide Statement-VC.pdf | 11/29/2023 | 11/28/2025 |
Phthalate Esters Letter | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Phthalate free statement.pdf | 11/29/2023 | 11/28/2024 |
California Prop. 65 | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | PROP 65 Statement.pdf | 10/17/2022 | 10/16/2024 |
California Prop. 65 | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | PROP 65 Statement.pdf | 10/17/2022 | 10/16/2024 |
Residual Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Residual Solvent Statement-VC.pdf | 11/29/2023 | 11/28/2024 |
Safety Data Sheet (SDS) | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | SDS__Ascorbic Acid.pdf | 3/24/2022 | 3/23/2025 |
Safety Data Sheet (SDS) | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | SDS__Ascorbic Acid.pdf | 3/24/2022 | 3/23/2025 |
Sewage Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Sewage Sludge Statement VC.pdf | 11/29/2023 | 11/28/2025 |
Sewage Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Sewage Sludge Statement.pdf | 6/5/2020 | 6/5/2022 |
Shelf Life | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Shelf Life Statement.pdf | 11/29/2023 | 11/28/2025 |
Product Specification Sheet | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | SPEC.pdf | 2/7/2021 | 2/7/2024 |
Shelf Life | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | SPEC.pdf | 2/7/2021 | 2/7/2023 |
Suitability Requirements | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Suitability Requirements.pdf | 7/7/2020 | 7/7/2023 |
Suitability Requirements | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | Suitability Requirements.pdf | 11/26/2023 | 11/25/2026 |
Natural | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | Synthetic Statement.pdf | 6/11/2021 | 6/11/2022 |
BSE - TSE | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | TSE BSE VC.pdf | 11/26/2023 | 11/25/2026 |
BSE - TSE | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | TSE BSE.pdf | 6/3/2020 | 6/3/2023 |
WADA/NSF/NFL Statement | Shandong Lianmeng International Trading - Shandong, China - Mitsubishi | WADA Statement - ascorbic acid.pdf | 12/6/2023 | 12/5/2025 |
WADA/NSF/NFL Statement | Shandong Tianli Pharmaceutical Co., Ltd. - Souguang - Mitsubishi | WADA Statement.pdf | 6/5/2020 | 6/5/2022 |